Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2001-08-23
2004-06-01
Ketter, James (Department: 1636)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Reexamination Certificate
active
06743626
ABSTRACT:
FIELD OF THE INVENTION
The present invention generally relates to the field of oral prosthetics and tissue engineering. More specifically, a novel, artificial fluid secreting prosthesis for non-invasive insertion is disclosed. Further, methods of use of the foregoing are provided.
BACKGROUND OF THE INVENTION
For many years, investigators have studied diseases of the mouth and mechanisms by which salivary glands produce their secretions. (Bricker et al., eds., “Oral Diagnosis, Oral Medicine and Treatment Planning,” Lea & Febiger, Philadelphia, Pa., 1994; Baum et al.,
Methods Enzymol,
192:26-37 (1990); and Baum et al.,
Ann. NY Acad. Sci,
694:17-23 (1993)). Salivary glands have provided a valuable experimental model for generations of scientists interested in neurofunctional controls, from Claude Bernard and Ivan Pavlov to the present day. They are highly responsive epithelial tissues whose function can be readily and non-invasively measured. (Young et al., “Secretion of salivary and salt glands,”
Membrane Transport in Biology
, Vol 4, Giebisch et al., eds., Springer-Verlag, Berlin/New York, 1979:563-674; and Mandel,
J. Amer. Dent. Assoc.,
119:298-304 (1989)).
All salivary glands are compound tubuloalveolar glands. Small intrinsic salivary glands are scattered within the mucosa of the tongue, palate, lips, and cheeks. Saliva from these glands keeps the mouth moist at all times. Large extrinsic salivary glands secrete saliva during eating. In humans there are three extrinsic salivary glands (parotid, submandibular, and sublingual) that lie external to the mouth but are connected to the mouth through ducts. From an open mouth, the cannulation of the duct orifice, a procedure that in humans requires no anesthesia, affords direct access to the luminal membrane of virtually every cell in this secretory tissue.
Salivary glands consist almost entirely of well-differentiated epithelial cells that exist as a monolayer bordering on an extensively arborized lumen. (Cook et al., “Secretion by the major salivary glands,”
Physiology of the Gastrointestinal Tract
, Johnson, ed., Raven, New York, 1994:1061-1117). The secretory cells of these glands produce a watery secretion composed of enzymes and ions, while mucous cells produce mucous. Depending on the type of salivary gland, different amounts of secretory cells and mucous cells are present
There are many subjects who effectively have lost all functional salivary epithelium, both acinar and ductal, and experience severe salivary hypofunction. Each year in the United States alone, approximately 30,000 individuals undergo therapeutic ionizing radiation (IR) for head and neck malignancies. (Silverman,
Clin. Geriatric Med.,
8:529-541 (1992)). Acinar cells—the fluid, salt, and protein-secretory cell type in the glands—are very sensitive to radiation and are readily destroyed during radiation therapy. (Kashima et al.,
Am. J. Roentgenol Radium Ther. Nucl. Med.,
94:271-291 (1965)). In addition to irradiated subjects, many other individuals with Primary Sjogren's syndrome or an autoimmune exocrinopathy also exhibit salivary gland hypofunction. In consequence, individuals having hypofunctional salivary glands suffer from rampant dental caries (decay), frequent mucosal infections (such as oral Candidiasis), dysphagia (swallowing difficulties), as well as, considerable pain and discomfort.
At present, there is no conventional effective treatment of salivary gland hypofunction. While gene transfer to glandular epithelial tissue offers promise, at present, the expression of transferred genes is transient at best and many subjects lack glandular epithelial tissue for gene transfer altogether. The transplantation of mammalian salivary glands has also been tried but this option is clinically undesirable because of an insufficient donor supply, the continuous need for immunosuppression, and surgical difficulty. (Eid et al.,
Transplantation,
64:679-683 (1997)). In view of the foregoing, and not withstanding the various efforts exemplified in the prior art, there remains a need for an artificial fluid secreting prosthesis and a deployment methodology for oral implantation so as to treat individuals suffering from salivary gland hypofunction.
BRIEF SUMMARY OF THE INVENTION
Compositions and methods based on the discovery of an artificial fluid secreting prosthesis are disclosed. In a first set of experiments, it is demonstrated that subjects having irradiated salivary gland cells can be induced to secrete fluid subsequent to transfer of a gene encoding aquaporin-1 (AQP1). In a second set of experiments, it is shown that heterologous genes transferred to salivary gland cells, such as human &agr;1-antitrypsin (h&agr;1AT) and human growth hormone (hGH), can be expressed in vivo and these products are detected in the blood of the recipient organism. In a third set of experiments, an artificial salivary gland is constructed. This device has a support, an attachment surface joined to the support, and joined to the attachment surface are a polarized monolayer of allogenic or autologous cells that are engineered to secrete ions and water unidirectionally.
REFERENCES:
patent: 4745101 (1988-05-01), Aonuma
patent: 5462870 (1995-10-01), Chopra
patent: 5741671 (1998-04-01), Agre
patent: WO 9745533 (1997-12-01), None
patent: WO 9901538 (1999-01-01), None
Anderson, W. French, Human gene therapy, Apr. 1998, Nature, 391 (Supp): 25-30.*
Kmiec, Eric B., Gene Therapy, May 1999, American Scientist, 87: 240-247.*
Verma, Inder M., Gene therapy—promises, problems and prospects, Sep. 1997, Nature, 389: 239-242.*
Aframian et al. Tissue Compatibility of Two Biodegradable Tubular Scaffolds Implanted Adjacent to Skin or Buccal Mucosa in Mice, 2002, Tissue Engineering, 8(4): 649-659.*
Adesanya, M. R., et al. (1996) Immediate Inflammatory Responses to Adenovirus-Mediated Gene Transfer in Rat Salivary Glands. Hum. Gene Ther. 7:1085-1093.
Baum, B. J. (1993) Principles of Saliva Secretion, Ann. N. Y. Acad. Sci. 694:17-23.
Baum, B. J., et al. (1990) Dispersed Salivary Acinar Cell Preparations for Use in Studies of Neuroreceptor-Coupled Secretory Events. Methods Enzymol. 192:26-37.
Baum, B. J., et al. (1999) Re-engineering the Functions of a Terminally Differentiated Epithelial Cell In Vivo. Ann. N.Y. Acad. Sci. 875:294-300.
Bramson, J. L., et al. (1995) The use of adenoviral vectors for gene therapy gene transfer in vivo. Curr. Opin. Biotechnol. 6:590-595.
Cook, D. I., et al. (1994) Secretion by the Major Salivary Glands. In Physiology of the Gastrointestinal Tract 1061-1117.
Delporte, C., et al. (1997) Relationship between the Cellular Distribution of the &agr;v&bgr;3/5Integrins and Adenoviral Infection in Salivary Glands. Lab. Invest 77(2):167-173.
Delporte, C., et al. (1998) Relationship between Adenovirus-Mediated Aquaporin 1 Expression and Fluid Movement across Epitheliel Cells. Biochem. Biophys. Res. Commun. 246:584-588.
Delporte, C., et al. (1997) Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. PNAS USA 94:3268-3273.
Eid, A., et al. (1997) Salivary Gland Transplantation: A Canine Model. Transplantation 64(5):679-683.
Goldfine, I. D., et al. (1997) The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract. Nature Biotechnol. 15:1378-1382.
He, X., et al. (1998) Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther. 5:537-541.
Hoffman, M. P., et al. (1996) Role of laminin-1 and TGF-&bgr;3 in acinar differentiation of a human submandibular gland cell line (HSG). J. Cell Sci. 109:2013-2021.
Kagami, H., et al. (1996) Evidence for the Systemic Delivery of a Transgene Product from Salivary Glands. Hum. Gene Ther. 7:2177-2184.
Kagami, H., et al. (1998) Repetitive Adenovirus Administration to the Parotid Gland: Role of Immunological Barriers and Induction of Oral Tolerance. Hum. Gene Ther. 9:305-313.
Kashima, H. K., et al. (1965) Postirradiation Sialadenitis. Am. J. Roentgenol. Radium Ther.
Baum Bruce J.
Cukierman Edna
Mooney David
Yamada Kenneth M.
Akhaven Ramin
Ketter James
Knobbe Martens Olson & Bear LLP
The United States of America as represented by the Department of
LandOfFree
Artificial salivary gland does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Artificial salivary gland, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Artificial salivary gland will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3323590